Immunovia

Dr. Bryson Katona, a leading expert on inherited gastrointestinal cancers, will present ”Controversies in Pancreatic Cancer Surveillance Guidelines and the Potential Role for Blood Based Biomarker Testing”, at an Immunovia-sponsored symposium on October 10, 2025.

In his presentation, Dr. Katona, will share the major pancreatic cancer surveillance guidelines and the key differences in recommended patient populations, imaging approaches, and surveillance intervals. He will also highlight the reasons health systems screen high-risk patients differently and how emerging tools like blood-based biomarker testing may influence future pancreatic cancer surveillance.

Bryson Katona, MD, is Associate Professor of Medicine and Genetics at University of Pennsylvania. He is also the Past President of CGA-IGC. As a member of Immunovia’s Scientific Advisory Board, Dr. Katona has collaborated on research projects with the company and offers the PancreaSure test at the high-risk surveillance program of University of Pennsylvania.